AVI BioPharma Inc. said it's changed its name to Sarepta Therapeutics Inc. and also enacted a one-for-six reverse stock split.
The Bothell company said its shares will being trading (on a split-adjusted basis) on the NASDAQ Global Market under the symbol "SRPT" beginning Thursday.
The company said its "programs include its lead therapeutic candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy, as well as potential treatments for the lethal hemorrhagic fever viruses Ebola and Marburg."
"The…
AVI BioPharma Inc. said it's changed its name to Sarepta Therapeutics Inc. and also enacted a one-for-six reverse stock split.
The Bothell company said its shares will being trading (on a split-adjusted basis) on the NASDAQ Global Market under the symbol "SRPT" beginning Thursday.
The company said its "programs include its lead therapeutic candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy, as well as potential treatments for the lethal hemorrhagic fever viruses Ebola and Marburg."
"The…
